Receptor utilization by FIVFca and FIVPle-E. HIV-luciferase pseudotypes were prepared bearing the Envs of either FIVFca or FIVPle-E and used to infect MCC cells stably transduced with retroviral vectors bearing feline (domestic cat) CD134 (fCD134), feline CD134 CRD1/human CD134 chimera (fCRD1/hCD134), human CD134 (hCD134), or vector only (control) (A); NP2 cells transduced with retroviral vectors bearing lion CD134, lion CXCR4, feline CD134, or feline CXCR4 in combination (B); or lion CD134, lion CXCR4, feline CD134, or feline CXCR4 alone or lion CXCR4 in combination with lion or feline CD134 (C). Cells were infected with pseudotypes bearing FIVPle-E or FIVFca-GL8 (A); FIVFca-PPR, GL8, 1419, TM2, or CPG41 (50) (B); or FIVPle-E or FIVFca-GL8 (C). Histograms are representative of the results of at least two independent experiments and display means ± standard errors (n = 3).